Latest News & Features
Americas
In the competitive world of cancer treatment it’s becoming ever more important to stand out from the crowd. LSIPR speaks to TapImmune’s chief executive Glynn Wilson on why he thinks the company does. 29 October 2014
Asia
A recent decision from the IPAB on the patent eligibility of biological processes could change the biotech playing field in India, say Swarup Kumar and Shivaarti Bajaj. 29 October 2014
Big Pharma
Pharmaceutical company Bristol-Myers Squibb has agreed a deal that gives it the option of acquiring drug maker F-star Alpha and one of its breast and gastric cancer treatments. 28 October 2014
Americas
Pharmaceutical company AstraZeneca has filed a patent infringement lawsuit against drug maker Pharmadax after it applied to market a generic version of a schizophrenia and bipolar disorder treatment. 27 October 2014
Generics
A US court has rejected attempts by two companies to market generic versions of a birth control pill owned by pharmaceutical company Actavis. 24 October 2014
Generics
The South African government has been urged to act quickly and honour its plans to overhaul its patent laws, which some have claimed could lead to an increase in affordable generic medicines. 23 October 2014
Americas
Pharmaceutical company Eli Lilly has said its profits fell by more than 50% in the most recent quarter, citing patent expirations and generic competition as contributing factors. 23 October 2014
Big Pharma
Pharmaceutical company Roche has announced it will be building a new multi-billion research and development centre. 22 October 2014
Americas
The US Court of Appeals for the Federal Circuit has limited a judge’s power to enforce local rules in a patent dispute involving pharmaceutical company Pfizer and an anti-cancer treatment company. 21 October 2014
Big Pharma
Pharmaceutical and biologics company AstraZeneca and the University of Cambridge have teamed up as part of a programme aimed at increasing life science-related research and teaching. 20 October 2014